iAnthus Strengthens Portfolio with $36.5M Sale of Select Arizona Assets to Sonoran Roots
NEW YORK and TORONTO, Feb. 07, 2025 (GLOBE NEWSWIRE) — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, […]
Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans
Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an […]
ParaZero to Attend IDEX UAE, Leading Defense and Security Exhibition
Tel Aviv, Israel, Feb. 07, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “Company or “ParaZero”), an aerospace […]
Arq Schedules Q4 & FY 2024 Earnings Conference Call and Upcoming Investor Events
GREENWOOD VILLAGE, Colo., Feb. 07, 2025 (GLOBE NEWSWIRE) — Arq, Inc. (NASDAQ: ARQ) (the “Company” or “Arq”), a producer of […]
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused […]
Arq Provides Update on Transformational GAC Project
Construction of Arq’s GAC production facility remains on schedule, with initial production expected in Q1 2025 Customer negotiations for GAC […]
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
HANOVER, Md., Feb. 07, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical […]
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing […]
LiveOne (NASDAQ: LVO) to Announce Third Quarter Fiscal Year 2025 Financial Results and Host Investor Webcast on Friday, February 14, 2025
LOS ANGELES, Feb. 07, 2025 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), an award-winning, creator-first music, entertainment, and technology platform, plans […]
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase […]
